Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hawthorne Pharmaceuticals was a specialty pharmaceutical company headquartered in Madison, Mississippi, that focused on the development and commercialization of prescription products for the respiratory, pediatric, and prenatal markets. The company's portfolio included a range of treatments for cough, cold, and allergy symptoms, as well as nutritional supplements for expectant mothers. In December 2011, Hawthorne was acquired by Mission Pharmacal Company, a family-owned pharmaceutical firm based in Texas. This acquisition enabled Mission Pharmacal to expand its presence in the pediatric and respiratory therapeutic areas by integrating Hawthorne's established product lines. Prior to its acquisition, Hawthorne was recognized for its commitment to providing high-quality, effective medications tailored to the needs of pediatric patients and their caregivers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hawthorne Pharmaceuticals.